Plain-English translation of NCT05217810 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Asthma research guide →This trial is monitoring how well Atectura (a combination inhaler containing two medications) works for adolescents and adults with asthma in real-world settings. Your doctor will prescribe the medication at the dose that's right for you, and the research team will track how you're doing over 24 weeks. This is a monitoring study, not a test of a brand-new treatment — the medication is already approved and used by patients.
Local health authorities in Korea require ongoing monitoring of how this medication performs once it's being used by patients in everyday life, rather than just in controlled research settings. This helps ensure the treatment continues to be safe and effective for people like you.
You likely qualify if…
You likely don't qualify if…
Your doctor will prescribe the medication at the dose appropriate for your asthma, and you'll use it as directed for 24 weeks. The study team will check in with you to see how you're managing and whether you're having any concerns — no extra tests or special monitoring beyond your normal asthma care is required. You'll need to sign a consent form agreeing to let the research team use your health information for this safety monitoring study.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
South Korea